$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
₹190
INTRODUCTION HEPAKIND contains Ursodeoxycholic acid (also known as Ursodiol) which is a Gallstone dissolving agent. It is used to dissolve gall bladder stones (made up of cholesterol) and prevents them from forming back. It can also be used to treat a type of liver disease called primary bilia...
HEPAKIND contains Ursodeoxycholic acid (also known as Ursodiol) which is a Gallstone dissolving agent. It is used to dissolve gall bladder stones (made up of cholesterol) and prevents them from forming back. It can also be used to treat a type of liver disease called primary biliary cholangitis. Primary biliary cholangitis (also known as primary biliary cirrhosis) is a long-term liver disease in which the tubes carrying a digestive fluid called bile (bile ducts) are injured, inflamed, and permanently damaged. As a result, it can cause yellow or white bumps under the skin or eyes, dark urine, and abnormally swollen stomach with pain with frequent nausea, weight loss and tiredness. HEPAKIND can also be used to treat liver and biliary diseases caused due to cystic fibrosis (an inherited disorder that affects major organs) in children aged between 6-18 years.
HEPAKIND is a liver protectant medication. It works by reducing cholesterol levels in the blood which is dissolving the gall bladder stones made up of cholesterol. It also improves liver functions by protecting the liver cells against the injury caused by toxic bile acid.
Before taking HEPAKIND inform your doctor, if you have any other liver problems apart from gall stones and biliary cirrhosis. While taking HEPAKIND, your doctor would regularly monitor your liver function to access how you respond to the treatment. HEPAKIND is not recommended for use in pregnant women. Women of childbearing age should use a suitable non-hormonal contraceptive method like condemn or copper-IUD to avoid getting pregnant. The most common side effect of HEPAKIND is pasty stools. Consult your doctor if it bothers you.
HEPAKIND is a liver protectant medication. It works by reducing cholesterol levels in the blood by decreasing its production in the liver and by inhibiting its absorption in the intestines. As a result, it slowly breaks down the gall bladder stones made up of cholesterol. It also improves liver functions by protecting the liver cells against the injury caused by toxic bile acid, thereby improving liver health in diseased patients.
HEPAKIND should only be used under medical supervision. Swallow HEPAKIND with a glass of water and do not crush or chew it. Your doctor will decide the correct dose for you depending upon your age, body weight and disease condition. You can take HEPAKIND after a meal with a glass of milk or a small snack.
Stop taking HEPAKIND and contact your doctor if you experience:
Pasty stools or diarrhea:
Drink lots of fluids, such as water or juice, to avoid dehydration. Take plenty of rest. Do not take any medicines without speaking to a doctor.
HEPAKIND is not recommended for use in pregnant women unless clearly necessary. Consult your doctor before taking. Women of childbearing age should use a suitable non-hormonal contraceptive method to avoid getting pregnant while taking HEPAKIND.
HEPAKIND should be used with caution among breastfeeding women. Consult your doctor before taking.
Do not drive or operate any machines if your ability is affected by HEPAKIND.
Avoid consumption of alcohol while taking HEPAKIND, as it could aggravate your existing condition.
HEPAKIND should be used with caution in patients with kidney disease. Consult your doctor before taking.
HEPAKIND is not recommended for use in patients with an acute inflammation of gallbladder or bile ducts, blockage of bile ducts, biliary colic (cramp-like pain in the upper abdomen). Consult your doctor for advice.
Talk to your doctor if you are allergic to Ursodeoxycholic acid.
HEPAKIND should be used with caution in patients with heart disease. Consult your doctor before taking.
HEPAKIND is not recommended for use if you:
Use in Pediatrics:
HEPAKIND is generally used in children and adolescents (aged between 6-18 years). However, consult your doctor before taking.
Use in Geriatrics:
HEPAKIND should be used with caution in elderly patients. Consult your doctor before taking.
Before taking HEPAKIND, inform your doctor, if you are taking any of the following medicine:
Overdosage:
If you or anyone else accidentally take excess of HEPAKIND, consult your doctor immediately or visit the nearby hospital. Symptom of overdose can be prolonged diarrhea.
| Drug | : | Ursodeoxycholic acid (ursodiol) |
| Pharmacological Category | : | Gallstone dissolving Agents |
| Therapeutic Indication | : |
Primary biliary cirrhosis, gallstones, liver disease associated with cystic fibrosis |
| Dosage Forms | : | Tablet, Syrup |
Can HEPAKIND cause constipation?
There is no proper information regarding incidence of constipation while taking HEPAKIND. If you feel constipated, try to include fiber rich diet in your meals and drink plenty of water. Try to perform a brisk walk at least for 30 minutes regularly after consulting your doctor. If the symptom bothers you, contact your physician.
How to take HEPAKIND?
HEPAKIND is preferably taken after meals along with a glass of milk or a small snack. Swallow HEPAKIND with a glass of water and do not crush or chew it. Your doctor will decide the correct dose for you depending upon your age, body weight and disease condition.
How HEPAKIND works on my body?
HEPAKIND works by reducing cholesterol levels in the blood which eventually causes break down of the gall bladder stones. It also improves liver functions by protecting the liver cells against the injury caused by toxic bile acid, thereby improving liver health in diseased patients.
Is HEPAKIND safe to use in children?
Yes. HEPAKIND can be used to treat liver disease associated with cystic fibrosis in children aged between 6-18 years. However, consult your doctor for the correct dose and duration that suits your child.
How long should I use HEPAKIND to dissolve gall stones?
Your doctor will advise you to use HEPAKIND based on your condition. Generally, the duration of the treatment ranges between 3-4 months but may further get extended depending on the size of the gallstone that need to be dissolved. Make sure that you receive an uninterrupted therapy during this period and your doctor might suggest having a periodic X-ray or an ultrasound to access whether the stones were completely dissolved or not. Even after dissolution of gall stones, your doctor might still prescribe you HEPAKIND to avoid its recurrence.
What precaution I need to follow while taking HEPAKIND?
HEPAKIND must be used only under medical supervision. Do not stop taking HEPAKIND once your symptoms subside, without consulting your doctor, because it may lead to recurrence of gallbladder stones. Avoid alcohol consumption as it could further aggravate your liver disease and make sure to have regular check-ups of liver function as instructed by your doctor without fail to access your improvement.
1. KD. Tripathi. Antiemetic, Prokinetic and Digestant drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 671.
2. Keith A. Sharkey and John L. Wallace. Treatment of disorders of bowel motility and water flux; Antiemetics; Agents used in biliary and pancreatic disease. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1347.
3. Mitsubishi Tanabe Pharma Corporation. Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on March 2012] [Accessed on 24th March 2022] https://clinicaltrials.gov/ct2/show/NCT00200343
4. Keith D. Lindor, Kris V. Kowdley, Velimir A. C. Luketic, M. Edwyn Harrison, Timothy McCashland, Alex S. Befeler, Denise Harnois, Roberta Jorgensen, Jan Petz, Jill Keach, Jody Mooney, Carol Sargeant, Julie Braaten, Tamara Bernard, Debra King, Ellen Miceli, Jeff Schmoll, Tanya Hoskin, Prabin Thapa and Felicity Enders. High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis. NCBI; PMC US National Library of Medicine, National Institute of Health. September 2010. [Accessed on 24th March 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758780/
5. G Dinler, N Koçak, A Yüce, F Gürakan, H Ozen. Ursodeoxycholic acid therapy in children with cholestatic liver disease. NIH. National Library of Medicine. National Center for Biotechnology Information. Pubmed.gov. January-March 1999. [Accessed on 24th March 2022] https://pubmed.ncbi.nlm.nih.gov/10770681/
6. Glenmark Pharmaceuticals Europe Limited. Electronic Medicines Compendium (EMC). [Revised on March 2019] [Accessed on 24th March 2022] https://www.medicines.org.uk/emc/files/pil.10064.pdf